Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Revolution Medicines, Inc.
Mayo Clinic
Brigham and Women's Hospital
Pfizer
Mayo Clinic
University of Kentucky
Tempus AI
Swiss Cancer Institute
National Cancer Institute (NCI)
BeiGene
Incyte Corporation
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
Bank of Cyprus Oncology Centre
Alliance for Clinical Trials in Oncology
Ohio State University Comprehensive Cancer Center
Massachusetts General Hospital
NanOlogy, LLC
SWOG Cancer Research Network
ImmunoGenesis
University of Kentucky
Faeth Therapeutics
Yale University
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
Alethia Biotherapeutics
Elevation Oncology
Fundación GECP
Spanish Lung Cancer Group
University of Texas Southwestern Medical Center
EpicentRx, Inc.
Radiation Therapy Oncology Group
Hoosier Cancer Research Network
University of Pittsburgh
OncoNano Medicine, Inc.
Vergent Bioscience, Inc.
Sun Yat-sen University
Celgene
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
National Institutes of Health Clinical Center (CC)
Pfizer
Memorial Sloan Kettering Cancer Center
Novartis
Spanish Lung Cancer Group